Details for New Drug Application (NDA): 085639
✉ Email this page to a colleague
NDA 085639 describes CODEINE, ASPIRIN, APAP FORMULA NO. 3, which is a drug marketed by Scherer Labs and is included in one NDA. Additional details are available on the CODEINE, ASPIRIN, APAP FORMULA NO. 3 profile page.
The generic ingredient in CODEINE, ASPIRIN, APAP FORMULA NO. 3 is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.
The generic ingredient in CODEINE, ASPIRIN, APAP FORMULA NO. 3 is acetaminophen; aspirin; codeine phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; aspirin; codeine phosphate profile page.
Summary for 085639
| Tradename: | CODEINE, ASPIRIN, APAP FORMULA NO. 3 |
| Applicant: | Scherer Labs |
| Ingredient: | acetaminophen; aspirin; codeine phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 150MG;180MG;30MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
